Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sucralfate Slurry in Eosinophilic Esophagitis
NCT02353078Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sucralfate in eosinophilic esophagitis (EoE), sponsored by Mayo Clinic. Primary endpoint: Effectiveness of Sucralfate treatment at 4 weeks. Started Jan 2015; status: completed.
02
Drugs
sucralfate
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT02353078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02353078.